Drug Profile
Romurtide - Daiichi Pharmaceutical
Alternative Names: MuroctasinLatest Information Update: 15 Dec 1991
Price :
$50
*
At a glance
- Originator Daiichi Pharmaceutical
- Class Antibacterials; Peptide antibiotics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal Cancer
Most Recent Events
- 15 Dec 1991 Launched for Cancer in Japan (Unknown route)